XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery

Completed

Conditions studied: Atherosclerosis, Coronary Artery Disease

In brief

This trial is to assess physician-determined XIENCE V® EECSS acute performance, deliverability and resource utilization in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience

Key facts

Study ID
NCT00731237
Run by
Abbott Medical Devices
People needed
2517
Starts
2008-10-01
Expected to finish
2009-10-01
Last updated by the study team
2009-10-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.